ABC
EBS icon

Associated Banc-Corp’s Emergent Biosolutions EBS Stock Holding History

Associated Banc-Corp’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10
Closed -$1K – 463
2020
Q4 		$1K Hold
10
– – ﹤0.01% 909
2020
Q3 		$1K Buy
+10
New +$1.08K ﹤0.01% 861

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Associated Banc-Corp's EBS Position: Q1 2021 in Review

Associated Banc-Corp sold out of Emergent Biosolutions (EBS) in Q1 2021, closing a stake of 10 shares — an estimated $1K sold.

Associated Banc-Corp first reported a position in EBS in Q3 2020 and held it in 2 quarters. The position peaked at $1K in Q4 2020. 340 funds tracked by Wall St. Rank hold EBS as of Q1 2021.

  • Associated Banc-Corp reported no remaining Emergent Biosolutions position as of Q1 2021 after selling out during the quarter.
  • Associated Banc-Corp sold 10 Emergent Biosolutions shares in Q1 2021, an estimated $1K.
  • Associated Banc-Corp first reported a position in Emergent Biosolutions in Q3 2020 and held it in 2 quarters.
  • Associated Banc-Corp's Emergent Biosolutions position peaked at $1K in Q4 2020.
  • 340 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2021.

Based on Associated Banc-Corp's 13F filing for Q1 2021, filed 5 May 2021.